Every claim on this page is drawn from peer-reviewed human clinical trials. No speculation. No hype. Just the research.
Nicotinamide Mononucleotide (NMN) is a naturally occurring compound and direct precursor to NAD+, the coenzyme that powers every cell in your body. Found in trace amounts in broccoli, edamame, and avocado, NMN is the most direct dietary route to restoring NAD+ levels that decline with age.
NAD+ levels decrease by approximately 50% by midlife due to increased consumption by DNA-repair enzymes (PARPs) and sirtuins responding to chronic cellular stress. Lower NAD+ means reduced mitochondrial efficiency, impaired DNA repair, and diminished sirtuin activity - hallmarks of biological aging.
Multiple peer-reviewed human trials confirm NMN supplementation raises blood NAD+ levels significantly. A 2022 Keio University trial found NMN improved muscle strength and physical performance in older adults. A Cell Metabolism study confirmed blood NAD+ elevation in healthy adults within weeks, with no adverse effects reported.
Sublingual absorption allows NMN to pass directly through the oral mucosa into systemic circulation, bypassing gastric acid and first-pass liver metabolism. This delivery route results in faster absorption and potentially higher bioavailability than oral capsules.
Sirtuins (SIRT1-7) are NAD+-dependent enzymes that regulate DNA repair, gene expression, and cellular stress response. They require NAD+ as a co-substrate to function. As NAD+ declines, sirtuin activity drops - accelerating aging-related cellular deterioration. NMN restores the NAD+ pool, reactivating sirtuin function.
A 2021 clinical trial published in Cell Reports Medicine found that NMN supplementation improved aerobic capacity and muscle oxygen utilization in amateur runners. Participants showed statistically significant improvements in VO2 max and reduced fatigue markers. The mechanism: higher NAD+ supports mitochondrial efficiency and reduces oxidative stress during exercise.
Both NMN and NR (Nicotinamide Riboside) are NAD+ precursors, but NMN is one step closer to NAD+ in the biosynthesis pathway. Research suggests NMN may have a more direct route to cellular NAD+ restoration. A 2023 head-to-head study found NMN produced a greater increase in blood NAD+ levels compared to an equivalent dose of NR.
NMN is a naturally occurring compound present in all living organisms. Every published human clinical trial to date has shown NMN to be well-tolerated at doses up to 1200mg/day. No serious adverse events attributable to NMN have been reported. As with any supplement, consult your physician if you are pregnant, nursing, or on medications.
Mitochondria generate ATP - the cellular energy currency - through oxidative phosphorylation, a process that depends on NAD+. As NAD+ declines, mitochondrial efficiency drops, producing less energy and more oxidative damage. NMN restores the NAD+ pool required for mitochondrial electron transport, improving energy output and reducing cellular stress.
Human clinical trials have used doses between 100mg and 1200mg daily. The most common effective dose in published research is 250mg-500mg per day. Morning administration is commonly recommended as NAD+ metabolism aligns with circadian rhythms. Consistent daily use is key - cellular NAD+ restoration is cumulative, not immediate.
